Increased primary breast tumor expression of CD73 is associated with development of bone metastases and is a potential biomarker for adjuvant bisphosphonate use
Authors: Nataliia Petruk, Steven L. Wood, Walter Gregory, Ana Lopez-Guajardo, Maria Oliva, Mikko Mella, Jouko Sandholm, Arja Jukkola, Janet E. Brown, Katri S. Selander
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
